Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506

Citation
M. Mogi et al., Increase in level of tumor necrosis factor-alpha in 6-hydroxydopamine-lesioned striatum in rats is suppressed by immunosuppressant FK506, NEUROSCI L, 289(3), 2000, pp. 165-168
Citations number
25
Categorie Soggetti
Neurosciences & Behavoir
Journal title
NEUROSCIENCE LETTERS
ISSN journal
03043940 → ACNP
Volume
289
Issue
3
Year of publication
2000
Pages
165 - 168
Database
ISI
SICI code
0304-3940(20000811)289:3<165:IILOTN>2.0.ZU;2-G
Abstract
We compared in rats with 6-hydroxydopamine (8-OHDA)-induced hemiparkinsonis m the content of tumor necrosis factor (TNF)-alpha in the nigrostriatal dop aminergic region of the control side with that of the 8-OHDA-injected exper imental side, and explored the effects of 6-OHDA injection combined with th e immunosuppressant FK506 treatment (0.5 or 4 mg/kg per day for 2 weeks). T he ratios of the concentration of TNF-alpha in the striatum and substantia nigra on the 6-OHDA injection side to that on the control side in the 6-OHD A hemiparkinsonism rats were significantly higher than those in the control rats without 6-OHDA treatment, whereas those in the rats treated with 6-OH DA and FK506 were not significantly different from those in the control rat s. Thus FK506 attenuated increased TNF-alpha level in the nigrostriatal dop aminergic region injured by 6-OHDA treatment. (C) 2000 Published by Elsevie r Science Ireland Ltd.